← Back to Patent Explorer
US4647445A Expired / Lapsed US ⏱️ 0.0 years remaining

Radiolabelled lipoproteins and method for making same

Assignee: Massachusetts Institute of Technology
•
Filing: 1984-03-28
•
Granted: 1987-03-03
•
Expires: 2004-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Lipoproteins radiolabelled with an isotope of technetium substantially retain their native structure and biological function. The lipoproteins can be radiolabelled by simultaneous reduction of pertechnetate and lipoprotein with sodium dithionite at pH 8-9. The resulting radiolabelled lipoproteins can be used as probes for extracorporeal imaging to analyze lipoprotein metabolism.

Inventors

  • 👤 Robert S. Lees

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:49
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/12; A61K51/1217; A61K51/1224; A61K2123/00

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 64 words
A method for radiolabelling a low density lipoprotein with an isotope of technetium, said isotope selected from the gorup consisting of technetium-99 and technetium-99m, said method comprising: A. mixing said lipoprotein and technetium isotope with sodium dithionite at a pH environment between 8 and 9 to form a stable technetium-lipoprotein complex, and B. separating the technetium-lipoprotein complex from the material resulting from step A.
Claim 2
Independent Claim 64 words
A method for radiolabelling a low density lipoprotein with an isotope of technetium, said isotope selected from the gorup consisting of technetium-99 and technetium-99m, said method comprising: A. mixing said lipoprotein and technetium isotope with sodium dithionite at a pH environment between 8 and 9 to form a stable technetium-lipoprotein complex, and B. separating the technetium-lipoprotein complex from the material resulting from step A.
Claim 3
Dependent Claim 28 words
A method for radiolabelling a low density lipoprotein according to claim 1 wherein the molar ratio of reducing agent to technetium isotope is greater than 10 6 .
Claim 4
Dependent Claim 30 words
A method for radiolabelling a lipoprotein with an isotope of technetium according to claim 1 wherein the lipoprotein consists essentially of lipoproteins having a density of 1.025 to 1.050 g/ml.
Claim 5
Dependent Claim 32 words
A method for radiolabelling a lipoprotein with an isotope of technetium according to claim 1 wherein the technetium-lipoprotein complex is separated from the material resulting from step A by molecular sieve chromatography.
Claim 6
Dependent Claim 44 words
A method for radiolabelling a lipoprotein with an isotope of technetium according to claim 1 wherein the technetium-lipoprotein complex is separated from the material resulting from step A by filtration and washing through a controlled pore size filter that substantially retains the technetium-lipoprotein complex.
Claim 7
Independent Claim 50 words
A method for radiolabelling a low density lipoprotein with a technetium isotope, said isotope selected from the group consisting of technetium-99 and technetium-99m, said method comprising mixing the lipoprotein and the technetium isotope with sodium dithionite at a pH environment between 8 and 9 to form a stable technetium-lipoprotein complex.
Claim 8
Independent Claim 50 words
A method for radiolabelling a low density lipoprotein with a technetium isotope, said isotope selected from the group consisting of technetium-99 and technetium-99m, said method comprising mixing the lipoprotein and the technetium isotope with sodium dithionite at a pH environment between 8 and 9 to form a stable technetium-lipoprotein complex.
Claim 9
Dependent Claim 56 words
A radiolabelled probe prepared by A. exposing a low density lipoprotein and a technetium isotope, said isotope selected from the group consisting of technetium-99 and technetium-99m, to sodium dithionite at a pH environment between 8 and 9, to form a stable technetium-lipoprotein complex, and B. separating the technetium-lipoprotein complex from the material resulting from step A.
Claim 10
Dependent Claim 56 words
A radiolabelled probe prepared by A. exposing a low density lipoprotein and a technetium isotope, said isotope selected from the group consisting of technetium-99 and technetium-99m, to sodium dithionite at a pH environment between 8 and 9, to form a stable technetium-lipoprotein complex, and B. separating the technetium-lipoprotein complex from the material resulting from step A.
Claim 11
Dependent Claim 45 words
A radiolabelled probe prepared by exposing a low density lipoprotein and a technetium isotope, said isotope being selected from the group consisting of technetium 99m and technetium 99, with sodium dithionite at a pH environment between 8 and 9 to form a stable technetium-lipoprotein complex.
Claim 12
Dependent Claim 45 words
A radiolabelled probe prepared by exposing a low density lipoprotein and a technetium isotope, said isotope being selected from the group consisting of technetium 99m and technetium 99, with sodium dithionite at a pH environment between 8 and 9 to form a stable technetium-lipoprotein complex.
Claim 13
Dependent Claim 19 words
A technetium-99m-radiolabelled low density lipoprotein in a solution of sodium dithionite in a pH environment between 8 and 9.
Claim 14
Dependent Claim 19 words
A technetium-99m-radiolabelled low density lipoprotein in a solution of sodium dithionite in a pH environment between 8 and 9.
Claim 15
Dependent Claim 31 words
A probe for detecting accumulation of low density lipoproteins in an arterial wall, said probe comprising a technetium-99m-labelled low density lipoprotein in a solution having a pH between 8 and 9.
Claim 16
Dependent Claim 31 words
A probe for detecting accumulation of low density lipoproteins in an arterial wall, said probe comprising a technetium-99m-labelled low density lipoprotein in a solution having a pH between 8 and 9.
Claim 17
Independent Claim 103 words
A method for detecting accumulation of low density lipoproteins in an arterial wall, said method comprising the steps of A. preparing a technetium-99m-labelled low density lipoprotein in a solution having a pH between 8 and 9; B. injecting said labelled low density lipoprotein into the vascular system of a patient; C. subsequently viewing the patient's vascular system with extracorporeally-located detecting means capable of detecting the labelled low density lipoprotein; D. determining from said detecting means the locations of the labelled low density lipoproteins; and E. quantifying concentrations of the labelled low density lipoproteins at the locations to determine the acumulation of said lipoproteins.
Claim 18
Independent Claim 103 words
A method for detecting accumulation of low density lipoproteins in an arterial wall, said method comprising the steps of A. preparing a technetium-99m-labelled low density lipoprotein in a solution having a pH between 8 and 9; B. injecting said labelled low density lipoprotein into the vascular system of a patient; C. subsequently viewing the patient's vascular system with extracorporeally-located detecting means capable of detecting the labelled low density lipoprotein; D. determining from said detecting means the locations of the labelled low density lipoproteins; and E. quantifying concentrations of the labelled low density lipoproteins at the locations to determine the acumulation of said lipoproteins.

References Cited (Backward Citations)

US4364920A Cited
US4057617A Cited
US4293537A Cited
US4424200A Cited
US4472509A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-03-02 1990-09-01 1991-03-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-03-02 1994-09-01 1995-03-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-03-02 1998-09-01 1999-03-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag